辉瑞新冠药医保没谈成，这只A股开盘跌超8%！将生产仿制药？公司回应

七印授权

44ZRCCJGMC3FAS4OJ0TG5C9HSIWKTIBU1VJ3N928K3O3IQAYIR

2023-01-22 19:58:09

article

CA9D29EC96831C64301495BA0C5E83BC3D6D941936061C2A3575CE75F7D9C53E

zh-CN

4923CFCD2C90249044AAB7420DC1644D9EAE543A

13998406

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

8892c366e9c73a74aaed4345e36cd42678fc73e45a3580e4407c9c064eb6637d309f8134efaba84c8b03cd38d2f7638c9a1e33e5111694bba5ff8e7c5337fd721c

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"300000"},"type":"cm"}

yuanben_63cd9551bc8014.18058382

原本认证

3990AMIDTXM8SIR9MNP4SE9QBHSY08DBGVEBGIYRI7MI3B6EO1

https://www.yuanben.io/article/0d5a1d78-00f9-43fc-84a5-054bb2d05882

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}